Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)

Milena A. Gianfrancesco; Gabriela Schmajuk; Sarah Haserodt; Laura Trupin; Zara Izadi; Kashif Jafri; Stephen Shiboski; Marina Sirota; R. Adams Dudley; Jinoos Yazdany

doi:10.1007/s00296-017-3918-8

Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)

Milena A. Gianfrancesco, Gabriela Schmajuk, Sarah Haserodt, Laura Trupin, Zara Izadi, Kashif Jafri, Stephen Shiboski, Marina Sirota, R. Adams Dudley, Jinoos Yazdany

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.

Original language	English (US)
Pages (from-to)	319
Number of pages	1
Journal	Rheumatology International
Volume	38
Issue number	2
DOIs	https://doi.org/10.1007/s00296-017-3918-8
State	Published - Feb 1 2018
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2017, Springer-Verlag GmbH Germany, part of Springer Nature.

Access

10.1007/s00296-017-3918-8

OpenUrl availability

Full text

Cite this

Gianfrancesco, M. A., Schmajuk, G., Haserodt, S., Trupin, L., Izadi, Z., Jafri, K., Shiboski, S., Sirota, M., Dudley, R. A., & Yazdany, J. (2018). Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6). Rheumatology International, 38(2), 319. https://doi.org/10.1007/s00296-017-3918-8

Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6). / Gianfrancesco, Milena A.; Schmajuk, Gabriela; Haserodt, Sarah et al.
In: Rheumatology International, Vol. 38, No. 2, 01.02.2018, p. 319.

Research output: Contribution to journal › Comment/debate › peer-review

Gianfrancesco, MA, Schmajuk, G, Haserodt, S, Trupin, L, Izadi, Z, Jafri, K, Shiboski, S, Sirota, M, Dudley, RA & Yazdany, J 2018, 'Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)', Rheumatology International, vol. 38, no. 2, pp. 319. https://doi.org/10.1007/s00296-017-3918-8

@article{6735b5d9b5124d0690c544fb384f5cf6,

title = "Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)",

abstract = "The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.",

author = "Gianfrancesco, {Milena A.} and Gabriela Schmajuk and Sarah Haserodt and Laura Trupin and Zara Izadi and Kashif Jafri and Stephen Shiboski and Marina Sirota and Dudley, {R. Adams} and Jinoos Yazdany",

note = "Publisher Copyright: {\textcopyright} 2017, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2018",

month = feb,

day = "1",

doi = "10.1007/s00296-017-3918-8",

language = "English (US)",

volume = "38",

pages = "319",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - Correction to

T2 - Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)

AU - Gianfrancesco, Milena A.

AU - Schmajuk, Gabriela

AU - Haserodt, Sarah

AU - Trupin, Laura

AU - Izadi, Zara

AU - Jafri, Kashif

AU - Shiboski, Stephen

AU - Sirota, Marina

AU - Dudley, R. Adams

AU - Yazdany, Jinoos

PY - 2018/2/1

Y1 - 2018/2/1

N2 - The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.

AB - The given and family name of a co-author R. Adams Dudley was swapped in the published article. The correct given name is R. Adams and the family name is Dudley.

UR - http://www.scopus.com/inward/record.url?scp=85038844657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038844657&partnerID=8YFLogxK

U2 - 10.1007/s00296-017-3918-8

DO - 10.1007/s00296-017-3918-8

M3 - Comment/debate

C2 - 29273937

AN - SCOPUS:85038844657

SN - 0172-8172

VL - 38

SP - 319

JO - Rheumatology International

JF - Rheumatology International

IS - 2

ER -

Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety (Rheumatology International, (2017), 37, 10, (1611-1618), 10.1007/s00296-017-3782-6)

Abstract

Bibliographical note

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this